Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
Transcenta to Present "Trial in Progress" at ASCO-GI 2023 for TST001 (Osemitamab) Combination with Nivolumab, with or without Chemotherapy in Advanced G/GEJ Cancer 2023-01-18 08:00
IASO Bio Raises Nearly $75 Million in Series C1 Funding 2023-01-18 08:00
Asieris Appoints Dr. Linda Wu as Chief Development Officer 2023-01-18 07:00
Tanso Biosciences Expands Its Line-up with 250 Mouse GPCRs 2023-01-18 00:00
NOVARAD PROVIDES FREE DIGITAL HEALTH RECORD SHARING TECHNOLOGY TO HOSPITALS IN DEVELOPING COUNTRIES 2023-01-17 22:15
LePure Biotech Closes Series C Financing Co-Led by Novo Holdings, General Atlantic, and Goldman Sachs Asset Management 2023-01-17 22:00
LePure Biotech Closes Series C Financing Co-Led by Novo Holdings, General Atlantic, and Goldman Sachs Asset Management 2023-01-17 20:41
Henlius' Novel Anti-PD-1 mAb HANSIZHUANG (Serplulimab) Approved for the Treatment of ES-SCLC 2023-01-17 19:42
Ascletis Announces Entering into a Supply Agreement of Ritonavir Tablets with Simcere 2023-01-17 08:29
AffaMed Therapeutics to commercialize Galcanezumab for Migraine Prevention in Mainland China 2023-01-17 08:00
FDA Accepts GMP Plasmid DMF of OBiO Technology 2023-01-17 08:00
FAPON presents at 41st Annual J.P. Morgan Healthcare Conference 2023-01-16 22:09
Fiberstar, Inc. Launches New Organic Citrus Fibers for Food & Beverages 2023-01-16 22:05
CARsgen Therapeutics and Huadong Medicine Announce Collaboration Agreement For Zevorcabtagene Autoleucel In Mainland China 2023-01-16 18:00
MGI Demonstrates Strong Commitment to Expanding Genomic Access in Europe 2023-01-16 12:00
SD Biosensor Successfully Finishes JP Morgan Healthcare Conference 2023-01-13 15:11
DEBIOPHARM APPLIES EXTENDED-RELEASE FORMULATION EXPERTISE TO REDUCE TREATMENT FREQUENCY BURDEN FOR ACROMEGALY & GEP-NET PATIENTS 2023-01-12 17:00
JUNIPER BIOLOGICS PARTNERS WITH CARIS LIFE SCIENCES® FOR MOLECULAR PROFILING DISTRIBUTION IN SOUTH EAST ASIA 2023-01-12 13:02
iNtRON is finalizing the SAL200 Tech Transfer 2023-01-12 09:34
DEBIOPHARM APPLIES EXTENDED-RELEASE FORMULATION EXPERTISE TO REDUCE TREATMENT FREQUENCY BURDEN FOR ACROMEGALY & GEP-NET PATIENTS 2023-01-12 06:00
1 91 92 93 94 95 413